QSAM Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Update
15 nov. 2022 08h00 HE
|
QSAM Biosciences Inc.
Further Progress Demonstrated in Clinical Program Evaluating CycloSam® Radiopharmaceutical Drug Candidate for Treatment of Metastatic Bone Cancer AUSTIN, Texas, Nov. 15, 2022 (GLOBE...